PUBLISHER: QYResearch | PRODUCT CODE: 1604021
PUBLISHER: QYResearch | PRODUCT CODE: 1604021
Global Latex Particle for In-Vitro Diagnostics Market Insights, Forecast to 2030
The global Latex Particle for In-Vitro Diagnostics market is projected to grow from US$ 51.02 million in 2024 to US$ 70.25 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.48% during the forecast period.
At present, the market concentration of the latex particle for IVD industry is relatively high due to the high technology barrier. Key players include JSR Life Sciences, Merck, Bangs Laboratories, Thermo Fisher, VDO Biotech and so on. JSR Life Sciences is the largest player, accounting for 47.55% revenue share globally in 2023.
In terms of product types, the mainstream product on the market is carboxy-modified latex particles, which occupies more than 60% of the market share. As for product applications, latex immunoturbidimetry is the largest application direction, accounting for more than 50%.
For consumption, North America, China and Europe are the main consumption areas, cumulatively accounting for 93.27% of the global total sales in 2023.
In terms of production side, this report researches the Latex Particle for In-Vitro Diagnostics production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of Latex Particle for In-Vitro Diagnostics by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
Report Includes:
This report presents an overview of global market for Latex Particle for In-Vitro Diagnostics, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Latex Particle for In-Vitro Diagnostics, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Latex Particle for In-Vitro Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Latex Particle for In-Vitro Diagnostics sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Latex Particle for In-Vitro Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Latex Particle for In-Vitro Diagnostics sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including JSR Life Sciences, Merck, Bangs Laboratories, Thermo Fisher, Agilent, IKERLAT Polymers, Fujikura Kasei, CD Bioparticles, and VDO Biotech, etc.
Market Segmentation
By Company
- JSR Life Sciences
Table of Contents
1 Study Coverage
- 1.1 Latex Particle for In-Vitro Diagnostics Product Introduction
- 1.2 Market by Type
- 1.2.1 Global Latex Particle for In-Vitro Diagnostics Market Size by Type, 2019 VS 2023 VS 2030
- 1.2.2 Plain Latex Particles
- 1.2.3 Carboxy-Modified Latex Particles
- 1.2.4 Other
- 1.3 Market by Application
- 1.3.1 Global Latex Particle for In-Vitro Diagnostics Market Size by Application, 2019 VS 2023 VS 2030
- 1.3.2 Latex Immunoturbidimetry
- 1.3.3 Latex Agglutination Test
2 Global Latex Particle for In-Vitro Diagnostics Production
3 Executive Summary
4 Competition by Manufacturers
5 Market Size by Type
6 Market Size by Application
7 US & Canada
8 Europe
9 China
10 Asia (excluding China)
11 Middle East, Africa and Latin America
12 Corporate Profile
13 Industry Chain and Sales Channels Analysis
14 Latex Particle for In-Vitro Diagnostics Market Dynamics
15 Key Findings in the Global Latex Particle for In-Vitro Diagnostics Study
16 Appendix
List of Tables
- Table 1. Global Latex Particle for In-Vitro Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
- Table 2. Major Manufacturers of Carboxy-Modified Latex Particles
- Table 3. Global Latex Particle for In-Vitro Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
- Table 4. Global Latex Particle for In-Vitro Diagnostics Production Growth Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (L)
- Table 5. Global Latex Particle for In-Vitro Diagnostics Production by Region (2019-2024) & (L)
- Table 6. Global Latex Particle for In-Vitro Diagnostics Production by Region (2025-2030) & (L)
- Table 7. Global Latex Particle for In-Vitro Diagnostics Production Market Share by Region (2019-2024)
- Table 8. Global Latex Particle for In-Vitro Diagnostics Production Market Share by Region (2025-2030)
- Table 9. Global Latex Particle for In-Vitro Diagnostics Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
- Table 10. Global Latex Particle for In-Vitro Diagnostics Revenue by Region (2019-2024) & (US$ Million)
- Table 11. Global Latex Particle for In-Vitro Diagnostics Revenue by Region (2025-2030) & (US$ Million)
- Table 12. Global Latex Particle for In-Vitro Diagnostics Revenue Market Share by Region (2019-2024)
- Table 13. Global Latex Particle for In-Vitro Diagnostics Revenue Market Share by Region (2025-2030)
List of Figures
